A new study has found that many of the stereotypes surrounding cannabis are untrue, and that cannabis consumers are among the “most well-adjusted and successful of American adults”. According to the study by BDS Analytics; “Public support for cannabis legalization is stronger today than ever before, yet the “stoner” stereotype — apathetic, unsuccessful, flaky — …
Cannabidiol (CBD) may be beneficial in the treatment of psychiatric/cognitive symptoms associated with neurodegeneration, according to a new study. The study, published by the journal Frontiers in Pharmacology, was also published online by the U.S. National Institute of Health. “Beneficial effects of cannabidiol (CBD) have been described for a wide range of psychiatric disorders, including …
New York’s Assembly Health Committee has overwhelmingly passed a bill that would add severe menstrual cramps – know as dysmenorrhea – to the state’s list of qualifying medical marijuana conditions. The committee gave approval to Assembly Bill 582 with an overwhelming 21 to 2 vote. The measure now moves towards a vote by the full …
Cannabinoids may provide an effective treatment option for Alzheimer’s disease, according to new research published in the European Journal of Pharmacology, and e-published ahead of print by the U.S. National Institute of Health. “Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by neuroinflammation, extensive deposits of amyloid-β aggregates, and loss of memory and cognitive abilities”, …
Cannabis use doesn’t harm eyesight quality, according to a new study published by the journal Optometry and Vision Science. According to researchers; “The aim of this study was to investigate if heavy marijuana smoking is associated with a poor quality of eyesight compared with light/no use of marijuana.” To conduct the study, “The National Longitudinal …
Cannabinoids have therapeutic potential in oxidative stress-related acute or chronic neurodegenerative disorders from stroke, multiple sclerosis and traumatic brain injury to Alzheimer`s and Parkinson`s diseases, according to a new study. The study, conducted by researchers at the National Institute of Health (NIH) and Rutgers New Jersey Medical School, is being published in the journal Antioxidants & …
Activation of the body’s cannabinoid receptors through spinal infusion is effective at blocking pain, according to a new study published by the journal Regional Anesthesia and Pain Medicine. “Cannabinoid receptors (CB1R/CB2R) are known to play important roles in pain transmission”, begins the study’s abstract. “In this study, we investigated the effects of continuous intrathecal infusion …
A new study published by the journal Neurochemical Research, and published online by the U.S. National Institute of Health, has confirmed past research that shows cannabidiol to be an anti-seizure agent. For the study; “The National Institute of Neurological Disorders and Stroke (NINDS) funded Epilepsy Therapy Screening Program (ETSP) investigated CBD in a battery of …
Cannabis use is an effective treatment option for those with Tourette’s Syndrome, according to a new study published in the Journal of Neuropsychiatry and Clinical Neuroscience. For the study, which was published online by the U.S. National Institute of Health, “The authors retrospectively evaluated effectiveness and tolerability of cannabis in 19 adults with Tourette syndrome”. …
By Paul Armentano, NORML Deputy Director African Americans in Virginia are arrested for marijuana possession at more than three times the rates of whites, and this disparity is rising. This is according to an analysis of statewide arrest data by Virginia Commonwealth University’s Capital News Service. Researchers reviewed 160,000 state and local arrest records from …
